Epithelial to Mesenchymal Transition in Arsenic-transformed Cells Promotes Angiogenesis Through Activating β-catenin-vascular Endothelial Growth Factor Pathway

Overview

Journal Toxicol Appl Pharmacol

Specialties Pharmacology
Toxicology

Date 2013 May 7

PMID 23643801

Citations 29

Authors

Zhishan Wang

Brock Humphries

Hua Xiao

Yiguo Jiang

Chengfeng Yang

Affiliations

Soon will be listed here.

Abstract

Arsenic exposure represents a major health concern increasing cancer risks, yet the mechanism of arsenic carcinogenesis has not been elucidated. We and others recently reported that cell malignant transformation by arsenic is accompanied by epithelial to mesenchymal transition (EMT). However, the role of EMT in arsenic carcinogenesis is not well understood. Although previous studies showed that short term exposure of endothelial cells to arsenic stimulated angiogenesis, it remains to be determined whether cells that were malignantly transformed by long term arsenic exposure have a pro-angiogenic effect. The objective of this study was to investigate the effect of arsenic-transformed human bronchial epithelial cells that underwent EMT on angiogenesis and the underlying mechanism. It was found that the conditioned medium from arsenic-transformed cells strongly stimulated tube formation by human umbilical vein endothelial cells (HUVECs). Moreover, enhanced angiogenesis was detected in mouse xenograft tumor tissues resulting from inoculation of arsenic-transformed cells. Mechanistic studies revealed that β-catenin was activated in arsenic-transformed cells up-regulating its target gene expression including angiogenic-stimulating vascular endothelial growth factor (VEGF). Stably expressing microRNA-200b in arsenic-transformed cells that reversed EMT inhibited β-catenin activation, decreased VEGF expression and reduced tube formation by HUVECs. SiRNA knockdown β-catenin decreased VEGF expression. Adding a VEGF neutralizing antibody into the conditioned medium from arsenic-transformed cells impaired tube formation by HUVECs. Reverse transcriptase-PCR analysis revealed that the mRNA levels of canonical Wnt ligands were not increased in arsenic-transformed cells. These findings suggest that EMT in arsenic-transformed cells promotes angiogenesis through activating β-catenin-VEGF pathway.

Citing Articles

Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis.

Wang P, Liu Z, Sweef O, Xie J, Chen J, Zhu H Environ Int. 2024; 185:108494.

PMID: 38364571 PMC: 11375692. DOI: 10.1016/j.envint.2024.108494.

Update of the risk assessment of inorganic arsenic in food.

Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B EFSA J. 2024; 22(1):e8488.

PMID: 38239496 PMC: 10794945. DOI: 10.2903/j.efsa.2024.8488.

Epigenetic downregulation of O-methylguanine-DNA methyltransferase contributes to chronic hexavalent chromium exposure-caused genotoxic effect and cell transformation.

Wang Z, Liu Z, Wang P, Lin H, Rea M, Kondo K Environ Pollut. 2023; 341:122978.

PMID: 37995958 PMC: 11372728. DOI: 10.1016/j.envpol.2023.122978.

MicroRNA-Gene Interactions Impacted by Toxic Metal(oid)s during EMT and Carcinogenesis.

Tran F, Lee E, Cuddapah S, Choi B, Dai W Cancers (Basel). 2022; 14(23).

PMID: 36497298 PMC: 9741118. DOI: 10.3390/cancers14235818.

Toxic metals in the regulation of epithelial-mesenchymal plasticity: demons or angels?.

Chen X, Xu Y, Lau A Cancer Cell Int. 2022; 22(1):237.

PMID: 35897065 PMC: 9327425. DOI: 10.1186/s12935-022-02638-3.

References

Zhao Y, Tan Y, Haslam S, Yang C . Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. Toxicol Sci. 2010; 115(1):214-24. PMC: 2855353. DOI: 10.1093/toxsci/kfq030. View

Klemm F, Bleckmann A, Siam L, Chuang H, Rietkotter E, Behme D . β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis. 2010; 32(3):434-42. DOI: 10.1093/carcin/bgq269. View

Liu L, Jiang Y, Carpenter R, Jing Y, Peiper S, Jiang B . Role and mechanism of arsenic in regulating angiogenesis. PLoS One. 2011; 6(6):e20858. PMC: 3110823. DOI: 10.1371/journal.pone.0020858. View

Fang J, Xia C, Cao Z, Zheng J, Reed E, Jiang B . Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005; 19(3):342-53. DOI: 10.1096/fj.04-2175com. View

Zerlin M, Julius M, Kitajewski J . Wnt/Frizzled signaling in angiogenesis. Angiogenesis. 2008; 11(1):63-9. DOI: 10.1007/s10456-008-9095-3. View

Lee J, Dedhar S, Kalluri R, Thompson E . The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006; 172(7):973-81. PMC: 2063755. DOI: 10.1083/jcb.200601018. View

Iorio M, Croce C . microRNA involvement in human cancer. Carcinogenesis. 2012; 33(6):1126-33. PMC: 3514864. DOI: 10.1093/carcin/bgs140. View

Wang Z, Zhao Y, Smith E, Goodall G, Drew P, Brabletz T . Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci. 2011; 121(1):110-22. PMC: 3080188. DOI: 10.1093/toxsci/kfr029. View

Meng D, Wang X, Chang Q, Hitron A, Zhang Z, Xu M . Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol Appl Pharmacol. 2010; 244(3):291-9. DOI: 10.1016/j.taap.2010.01.004. View

10.

Celik I, Gallicchio L, Boyd K, Lam T, Matanoski G, Tao X . Arsenic in drinking water and lung cancer: a systematic review. Environ Res. 2008; 108(1):48-55. DOI: 10.1016/j.envres.2008.04.001. View

11.

Chervona Y, Arita A, Costa M . Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics. 2012; 4(7):619-27. PMC: 3687545. DOI: 10.1039/c2mt20033c. View

12.

Tokar E, Diwan B, Waalkes M . Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice. Toxicol Lett. 2012; 209(2):179-85. PMC: 3285471. DOI: 10.1016/j.toxlet.2011.12.016. View

13.

Benbrahim-Tallaa L, Waalkes M . Inorganic arsenic and human prostate cancer. Environ Health Perspect. 2008; 116(2):158-64. PMC: 2235216. DOI: 10.1289/ehp.10423. View

14.

Wang L, Son Y, Ding S, Wang X, Hitron J, Budhraja A . Ethanol enhances tumor angiogenesis in vitro induced by low-dose arsenic in colon cancer cells through hypoxia-inducible factor 1 alpha pathway. Toxicol Sci. 2012; 130(2):269-80. PMC: 3621366. DOI: 10.1093/toxsci/kfs242. View

15.

Weis S, Cheresh D . Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17(11):1359-70. DOI: 10.1038/nm.2537. View

16.

Liu J, Waalkes M . Liver is a target of arsenic carcinogenesis. Toxicol Sci. 2008; 105(1):24-32. PMC: 2734307. DOI: 10.1093/toxsci/kfn120. View

17.

Li A, Zhang C, Gao S, Chen F, Yang C, Luo R . TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice. Oncogene. 2012; 32(18):2273-81, 2281e.1-12. PMC: 3460142. DOI: 10.1038/onc.2012.253. View

18.

Tapio S, Grosche B . Arsenic in the aetiology of cancer. Mutat Res. 2006; 612(3):215-246. DOI: 10.1016/j.mrrev.2006.02.001. View

19.

Zhao C, Young M, Diwan B, Coogan T, Waalkes M . Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997; 94(20):10907-12. PMC: 23527. DOI: 10.1073/pnas.94.20.10907. View

20.

Wang Z, Yang J, Fisher T, Xiao H, Jiang Y, Yang C . Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ Health Perspect. 2011; 120(1):92-7. PMC: 3261952. DOI: 10.1289/ehp.1104061. View